Brigit Biofarmaka Teknologi Tbk. vs Singaraja Putra Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Singaraja Putra Tbk. trades at Rp13,100 (market cap 16.29T, 13.16M 24h volume). The key difference: Singaraja Putra Tbk. is far larger — about 98.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Singaraja Putra Tbk. is more actively traded (13.16M versus 324K). Which is the better fit depends on your goals.
| OBAT | SINI | |
|---|---|---|
Market Cap | 166.01B | 16.29T |
Volume | 324K | 13.16M |
Lot | 3.24K | 131.6K |
Turnover | 77.68M | 174.44B |
Average Price | 239.75 | 13,255.29 |
Value | 77.68M | 174.44B |
Indicative Equilibrium Price | 240 | 13,100 |
Indicative Equilibrium Volume | 1 | 2.97K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Singaraja Putra Tbk (the Company) was established based on Notarial Deed No. 52 dated November 23, 2005 of Notary Sri Herawati Anwar Effendi, S.H. The Company commenced commercialoperations in 2006.
Read more on SINI →